论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
肥厚性梗阻性心肌病患者 PTSMA 前 V1 和 aVR 导联初始 r 波的预后意义
Received 13 October 2021
Accepted for publication 26 November 2021
Published 10 December 2021 Volume 2021:14 Pages 9589—9598
DOI https://doi.org/10.2147/IJGM.S343050
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Objective: Percutaneous transluminal septal myocardial ablation (PTSMA) is one of the septal reduction therapies without all satisfactory results in hypertrophic obstructive cardiomyopathy (HOCM) patients. Initial r-wave in leads V1 and aVR on the surface electrocardiography is the sign of ventricular septal base depolarization. Whether the initial r-wave in leads V1 and aVR is predictive of good mid-term response to PTSMA in patients with HOCM remains unknown.
Design, Settings, and Participants: Among 546 consecutive patients evaluated in Fuwai Hospital (Beijing, China), we selected HOCM patients who underwent PTSMA. During the 3-year follow-up after PTSMA, primary outcomes included death, surgical myectomy, syncope, and NYHA classification III/IV.
Results: At last, 85 patients were selected, and were assigned to 3 groups based on the presence of initial r-wave in leads V1 and aVR. Through multivariable Cox and Kaplan–Meier method, patients with initial r-wave in both leads V1 and aVR were independently associated with a decreased risk of primary outcomes (HR: 0.112; 95% CI: 0.024 to 0.518; p = 0.005) during 3-years’ follow-up.
Conclusion: The results suggest that the presence of initial r-wave in both leads V1 and aVR on the surface 12-lead ECG is highly predictive of good mid-term response to PTSMA in patients with HOCM.
Keywords: hypertrophic obstructive cardiomyopathy, percutaneous transluminal septal myocardial ablation, electrocardiography